Ethical Considerations in Therapeutic Clinical Trials Involving Novel Human Germline-Editing Technology

Keyphrases

• Clinical Trials 100%
• Ethical Considerations 100%
• Human Germline Editing 100%
• Regulatory Agencies 50%
• Human Disease 50%
• Clinical Application 50%
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) 50%
• Early Phase Clinical Trials 50%
• Nonmaleficence 50%
• Potential Gains 50%
• International Community 50%
• Assessing Risk 50%
• Distributive Justice 50%
• Risk-benefit 50%
• Trial Participation 50%
• Beneficence 50%
• Moral Foundations 50%
• Normative Considerations 50%
• Human Germline 50%
• Germline Editing 50%
• Bioethical Principles 50%
• Bench-to-bedside Translation 50%

Biochemistry, Genetics and Molecular Biology

• Germline 100%
• Clinical Trial 100%
• Germ Cell 100%
• CRISPR 33%
• Beneficence 33%

Medicine and Dentistry

• Clinical Trial 100%
• Germ Cell 100%
• Clustered Regularly Interspaced Short Palindromic Repeat 33%
• Beneficence 33%
• Diseases 33%